iTeos Therapeutics Closes $125 Million Series B2 Financing

NEXT STORY
The Steadman Clinic Uses Modernizing Medicine’s Telehealth Solution to Treat Patients During COVID-19 Pandemic
PREV STORY
EyePoint Pharmaceuticals Provides COVID-19 Pandemic Business Operations Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Medicenna Announces Issuance of U.S. Patent Providing Added Intellectual Property Protection for its MDNA11 Program

author_avatar
NASDAQ Market News

ELIGARD® (Leuprolide Acetate) for Injectable Suspension Continues Growth Momentum With Securing Favorable Formulary Position as the Lowest WAC Priced, and Only Subcutaneously Administered Leuprolide Acetate for the Palliative Treatment of Advanced Prostate Cancer

author_avatar
NASDAQ Market News

Insights on the Diagnostic Specialty Antibodies Global Market to 2027 – Trend Outlook and Growth Opportunities

author_avatar
NASDAQ Market News